DaVita director granted 250 company shares

DaVita Inc. director Phyllis R. Yale received 250 shares of Common Stock as a grant or award, with no cash price per share reported.

Rhea-AI Filing Summary

DaVita Inc. director Phyllis R. Yale received 250 shares of Common Stock as a grant or award, with no cash price per share reported. This non-derivative acquisition increased her direct holdings to 14,563 DaVita shares, reflecting routine equity-based compensation rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 250 shares

Grant/Award 1 txn

Insider YALE PHYLLIS R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	250	$0.00	$0.00

Holdings After Transaction: Common Stock — 14,563 shares (Direct)

Key Figures

Shares granted: 250 shares Grant price: $0.0000 per share Shares held after grant: 14,563 shares +1 more

4 metrics

Shares granted 250 shares Common Stock grant to director on 2026-05-15

Grant price $0.0000 per share Reported transaction price for awarded shares

Shares held after grant 14,563 shares Total direct DaVita holdings following transaction

Transactions acquiring 1 transaction Non-derivative grant or award acquisition

Key Terms

Common Stock, Grant, award, or other acquisition, non-derivative, Form 4

4 terms

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

non-derivative financial

"transaction_type": "non-derivative""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DaVita (DVA) director Phyllis R. Yale report?

Phyllis R. Yale reported receiving 250 shares of DaVita Common Stock as a grant or award. The transaction was coded as an acquisition (A) and classified as a non-derivative, indicating equity compensation rather than an open-market trade.

Was the DaVita (DVA) insider transaction a purchase or a compensation grant?

The DaVita insider transaction was a compensation-related grant, not an open-market purchase. It is coded as a grant or award acquisition with a reported price per share of $0.0000, consistent with shares issued as part of director compensation.

How many DaVita (DVA) shares does Phyllis R. Yale hold after this Form 4?

After receiving the 250-share grant, Phyllis R. Yale directly holds 14,563 DaVita Common Stock shares. This total reflects her position following the reported acquisition and helps investors gauge the relative size of the newly awarded shares.

Does the DaVita (DVA) Form 4 show any insider stock sales?

The Form 4 shows no insider stock sales. It reports one acquisition transaction, a grant of 250 DaVita Common Stock shares, with zero shares listed as sold or disposed, and the net buy-sell share activity recorded as neutral in the summary.

Are there any derivative securities in this DaVita (DVA) insider filing?

This DaVita insider filing does not report any derivative securities. The transaction relates only to non-derivative Common Stock, and the derivative summary section is empty, indicating no options, warrants, or similar instruments were reported in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:11 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

YALE PHYLLIS R

(Last) (First) (Middle)

C/O DAVITA INC

2000 16TH STREET

(Street)

DENVER COLORADO 80202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		A		250	A	$0	14,563	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Stephanie N. Berberich, Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)